v3.26.1
Fair Value of Financial Instruments (Tables)
 6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Estimated Fair Values
The carrying amounts and estimated fair values of the Company’s financial instruments not carried at fair value, none of which are held for trading purposes, are as follows at June 30, 2026 and December 31, 2025:
Fair Value Measurements at
June 30, 2026 Using:
Carrying
Amount
Level 1Level 2Level 3Total
(Dollars in thousands)
Financial assets
Cash, due from banks, federal funds sold$118,821 $118,821 $— $— $118,821 
Loans, net2,720,485 — — 2,707,693 2,707,693 
Financial liabilities
Deposits$2,830,715 $— $2,705,611 $— $2,705,611 
Short-term Borrowings50,000 — 50,000 — 50,000 
Subordinated debt63,489 — 63,489 — 63,489 
Fair Value Measurements at
December 31, 2025 Using:
Carrying
Amount
Level 1Level 2Level 3Total
(Dollars in thousands)
Financial Assets:
Cash, due from banks, federal funds sold$134,116 $134,116 $— $— $134,116 
Loans, net2,627,281 — — 2,604,086 2,604,086 
Financial liabilities
Deposits$2,795,673 $— $2,692,104 $— $2,692,104 
Short-term Borrowings75,000 — 75,000 — 75,000 
Subordinated debt63,436 — 63,436 — 63,436 
Schedule of Fair Value of Assets Measured on a Recurring Basis
The following tables summarize the Company’s financial assets by level within the fair value hierarchy that were measured at fair value on a recurring basis:
June 30, 2026Fair ValueLevel 1Level 2Level 3
(Dollars in thousands)
Securities available-for-sale:
Residential mortgage-backed securities$296,139 $— $296,139 $— 
Commercial mortgage-backed securities5,957 — 5,957 — 
Asset backed securities21,301 — 21,301 — 
Corporate bonds1,944 — 1,944 — 
Total assets at fair value$325,341 $— $325,341 $— 
December 31, 2025Fair ValueLevel 1Level 2Level 3
(Dollars in thousands)
Securities available-for-sale:
Residential mortgage-backed securities$299,389 $— $299,389 $— 
Commercial mortgage-backed securities5,964 — 5,964 — 
Asset backed securities4,828 — 4,828 — 
Corporate bonds1,909 — 1,909 — 
Total assets at fair value$312,090 $— $312,090 $— 
Schedule of Fair Value of Assets Measured on a Nonrecurring Basis
June 30, 2026
(Dollars in thousands)
Total
Level 1
Level 2
Level 3
Collateral dependent loans, net$33,635 $— $— $33,635 
Total assets at fair value on a nonrecurring basis$33,635 $— $— $33,635 
June 30, 2025
(Dollars in thousands)
Total
Level 1
Level 2
Level 3
Collateral dependent loans, net$40,900 $— $— $40,900 
Total assets at fair value on a nonrecurring basis$40,900 $— $— $40,900 
The following table summarizes the Company’s financial instruments that were measured at fair value on a nonrecurring basis at June 30, 2026 and December 31, 2025:
June 30, 2026
(Dollars in thousands)TotalLevel 1Level 2Level 3
Collateral - Dependent loans, net$33,635 $— $— $33,635 
Total Assets at Fair Value on a nonrecurring basis$33,635 $— $— $33,635 
(Dollars in thousands)December 31, 2025
Collateral - Dependent loans, net$33,712 $— $— $33,712 
Total Assets at Fair Value on a nonrecurring basis$33,712 $— $— $33,712 
Schedule of Valuation Techniques of Assets Measured on a Nonrecurring Basis
June 30, 2026Fair valueValuation
technique		Unobservable
input		Range
Collateral dependent loans, net$33,635 Third party appraisal or
broker's price opinion		Management discount
for costs to sell		10%
June 30, 2025Fair valueValuation
technique		Unobservable
input		Range
Collateral dependent loans, net$40,900 Third party appraisal or
broker's price opinion		Management discount
for costs to sell		10%
The following table provides a description of the valuation technique, unobservable inputs, and qualitative information about the unobservable inputs for the Company’s assets and liabilities classified as Level 3 and measured at fair value on a nonrecurring basis as of June 30, 2026 and December 31, 2025:
June 30, 2026Fair ValueValuation TechniqueUnobservable Input
Range (Weighted
Average)
(Dollars in thousands)
Financial Instrument
Collateral - Dependent loans, net$33,635 Third party appraisal or broker’s price opinionManagement discount for costs to sell10 %
December 31, 2025Fair ValueValuation TechniqueUnobservable Input
Range (Weighted
Average)
(Dollars in thousands)
Financial Instrument
Collateral - Dependent loans, net$33,712 Third party appraisal or broker’s price opinionManagement discount for costs to sell10 %